Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307

OBJECTIVE: To evaluate safety, tolerability, seizure frequency, and regional variations in treatment responses with the AMPA antagonist, perampanel, in a large extension study during up to 3 years of treatment. METHODS: Patients ≥12 years old with partial-onset seizures despite treatment with 1–3 an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Epilepsia
Main Authors: Krauss, Gregory L, Perucca, Emilio, Ben-Menachem, Elinor, Kwan, Patrick, Shih, Jerry J, Clément, Jean-François, Wang, Xuefeng, Bagul, Makarand, Gee, Michelle, Zhu, Jin, Squillacote, David
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Full-Length Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283992/
https://ncbi.nlm.nih.gov/pubmed/24867391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.12643
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados